Delivery Order SPE2DB25D3003-SPE2DB25FPWFE
Award Date 4/21/25
Potential Completion Date 5/12/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for 28 tablets of Imbruvica 420 mg on September 11, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $7,575.75 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Imbruvica 140 mg tablets (28-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 280 mg tablets (28-count) under a firm fixed price contract. This non-set-aside award, issued on July 17, 2025, with an ultimate completion date of August 7, 2025, represents a pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count units) on September 8, 2025, with an ultimate completion date of September 29, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award status. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 mg tablets (28-count units) under a firm fixed price contract. This non-competitive set-aside delivery order is scheduled for completion by September 2, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply services through AmerisourceBergen's extensive federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Imbruvica 420 mg tablets (28-count packaging) with a contract value of $7,575.75 and completion date of September 26, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count) under a firm fixed-price contract valued at $22,727.25, with a completion date of August 29, 2025. This non-set-aside, competitively awarded contract represents a child delivery order issued against AmerisourceBergen's larger indefinite delivery vehicle with the DLA. The pharmaceutical distributor will perform under this contract at its corporate headquarters...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,151.52 on August 15, 2025, for the supply of Imbruvica 280 mg tablets (quantity: 28 units) under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The order is non-set-aside and competitively awarded, with an ultimate completion date of September 8, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Imbruvica 420 mg tablets (28-count) with a ceiling value of $76,839.82. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a $7,575.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Imbruvica 420 mg tablets (28-count units). This non-set-aside contract is scheduled for completion by September 10, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...